Skip to content
DraconiticResearch
Search Sources API
203,948 studies31 sourcesUpdated 30 min ago

Pharmacology & toxicology

3,013 studies233 in 7 days1,447 in 30 days

Filters
Type
Date
Clear

Latest

3,013 studies

  1. Mechanisms involved in the sex-dependent dopaminergic neurodegeneration induced by MDMA in a mouse model of adolescent drug exposure
    Giulia Costa, Laura Rullo, Vera Piera Leoni +12
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Full textPharmacology & toxicologyFrontiersCrossrefDOAJ
  2. From prediction to functional delivery: evaluating artificial intelligence in lipid nanoparticle design
    Ben Wu, Bin-Sheng He
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Pharmacology & toxicologyFrontiersCrossref
  3. Incomplete linkage disequilibrium between DPYD HapB3 variants: implications for pharmacogenetic phenotype assignment
    Miguel Álvarez-Montero, Fiorela C. Dueñas-López, Ramón Pardo-Puras +10
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Pharmacology & toxicologyFrontiersCrossref
  4. Elsholtzia Bodinieri vaniot dichloromethane extract exerts anti-inflammatory effects in acute lung injury mice by regulating the CCR1 and FLT1
    Yaxian Li, Rongyan Sun, Yi Feng +6
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Pharmacology & toxicologyFrontiersCrossref
  5. Protective effects of AKBA against hypoxia-induced cognitive dysfunction: potential involvement of SLC2A1, PTGS1, and BCL2L1
    Jiayi Wang, Liang Gao, Bowen Lv +9
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Pharmacology & toxicologyFrontiersCrossref
  6. Targeting MicroRNAs in the perioperative window to prevent surgery-induced metastasis and postoperative cancer recurrence
    Bin Yao, Binsong Qiu, Yin Zhang +1
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Pharmacology & toxicologyFrontiersCrossref
  7. The next frontier of peptide therapeutics: from targeted conjugates (PDC/ODC) to AI-driven safety-by-design
    Franck Morceau, YoungJun Kim, Yong-Jun Kwon +1
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Pharmacology & toxicologyFrontiersCrossref
  8. SENP3 loss in biliary tract cancer chemoresistance: substrate-specific control of fatty acid oxidation and mitophagy
    Wanxu Zheng, Shiji Xia, Wangdong Zhu +1
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Pharmacology & toxicologyFrontiersCrossref
  9. Diterpenoid tanshinones enhance CD8+ T-cell-mediated antitumor immunity in gastric cancer by suppressing ENO1 activity and glycolysis
    Jianing Guo, Xiaochen Ni, Kaiyuan Zhang +4
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Pharmacology & toxicologyFrontiersCrossref
  10. Malus domestica fruit-derived vesicles extract protect against upstream cellular hallmarks of vascular inflammation and epithelial barrier dysfunction
    Ilenia Pia Cappucci, Laura Basile, Lucia Sileo +11
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Pharmacology & toxicologyFrontiersCrossref
  11. Morusin induces GSDME-dependent pyroptosis in non-small cell lung cancer via the angiotensin II receptor type 2
    Xiaoyue Cui, Qiqi Zhang, Junjie Hu +13
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Pharmacology & toxicologyFrontiersCrossref
  12. Application of DASC and AUSC metrics in evaluating antimicrobial stewardship interventions in critically ill patients
    Sisi Wang, Yun Liu, Han Wang +3
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Pharmacology & toxicologyFrontiersCrossref
  13. MechTox: an audited benchmark for ordinal drug-induced liver injury prediction with uncertainty and mechanism-oriented interpretation
    Xiaohang Yang, Yanan Liu, Jingying Chen
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Pharmacology & toxicologyFrontiersCrossref
  14. Comparable TXNIP-inhibiting, anti-apoptotic and anti-diabetic effects of TIX100 and its individual enantiomers
    Gu Jing, Junqin Chen, Guanlan Xu +1
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Pharmacology & toxicologyFrontiersCrossref
  15. Effectiveness of a pharmacist-led protocol to manage cystitis in women, in France: the PharmaCyst’ open-label, multicenter, randomized, controlled, cluster study
    Arthur Piraux, Jean-François Hamel, Elsa Parot-Schinkel +3
    Research in Social and Administrative PharmacyPeer-reviewedCC BYPharmacology & toxicologyHAL
  16. Binary SiO2-CaO bioactive glass nanoparticles synthesis and colloidal stability investigated via in-situ SAXS for freeze-cast scaffolds
    Alexandra Pierron, Isabelle Morfin, Prescillia Lagarrigue +6
    Colloids and Surfaces A: Physicochemical and Engineering AspectsPeer-reviewedCC BYPharmacology & toxicologyHAL
  17. Single-cell multi-omics reveals cellular atlases and cell–cell interaction networks in metabolic dysfunction-associated steatotic liver disease (MASLD)
    Linshuang Dou, Wenying Qi, Jinyu Li +4
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Pharmacology & toxicologyFrontiersCrossref
  18. Cost-effectiveness of datopotamab deruxtecan versus chemotherapy as a first-line treatment for patients with advanced triple-negative breast cancer
    Zuojuan Xiang, Qiao Xia, Zhengxiong Li
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Pharmacology & toxicologyFrontiersCrossref
  19. Ceftazidime–avibactam monotherapy versus combination therapy for carbapenem-resistant Gram-negative bacterial infections: a secondary meta-analysis of predominantly critically ill cohorts
    Deyong Yue, Ling Zhu, Lihua Gu +4
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Pharmacology & toxicologyFrontiersCrossref
  20. Results of Operating the 2025 "Heat-related Illness Emergency Department Surveillance System".
    Jisuk Chae, Eunji Jung, Daeshik An +1
    Public health weekly reportPeer-reviewedCC BYFull textPharmacology & toxicologyEurope PMC
  21. Air pollution is associated with a distinct pathogen spectrum in community-acquired pneumonia: a prospective multicentre cohort study
    Max Kutzinski, Thomas Brenner, Saeed A. Khan +95
    PneumoniaPeer-reviewedCC BY 4.0Full textPharmacology & toxicologyPMC
  22. Shikonin: From Biosynthesis and Pharmacological Mechanisms to Translational Safety and Drug Delivery
    Namini Joshi, Prabhakar Semwal, Balwant Rawat +4
    ChembiochemPeer-reviewedCC BY 4.0Full textPharmacology & toxicologyPMC
  23. High‐Resolution Housing Data for Primary Prevention: What Address‐Level Records Add to National Lead‐Based‐Paint Screening
    Eric C. Ritter
    GeoHealthPeer-reviewedCC BY 4.0Full textPharmacology & toxicologyPMC
  24. PCB-Exposed Gut Microbiota Recapitulate Neurobehavioral Deficits and Reprogram Hippocampal Transcriptomic Signatures
    Y. P. Suh, R. J. Wilson, N. M. Breese +3
    bioRxivPreprintCC BYFull textPharmacology & toxicologybioRxiv
  25. Closing the loop: a needs-assessment informed model for embedding a non-allergist penicillin allergy de-labelling service in acute medicine, a quality improvement report
    Philip Toner, Annabel Glass, Cathal Donnelly +10
    JAC-Antimicrobial ResistancePeer-reviewedCC BY 4.0Full textPharmacology & toxicologyPMC